The Revised Geneva Score is a clinical prediction rule for estimating the probability of pulmonary embolism (PE) in patients. This scoring system is used in the adult population presenting with symptoms suggestive of PE, such as shortness of breath, chest pain, or unexplained cough.
The Revised Geneva Score is particularly useful in the emergency department or outpatient settings where PE is suspected. It helps clinicians decide whether further diagnostic testing (like CT pulmonary angiography) is needed. The score is based on various factors including age, previous history of DVT or PE, recent surgery or fracture, active malignancy, unilateral lower limb pain, hemoptysis, heart rate, and pain on lower limb deep venous palpation and unilateral edema.
There are no specific exclusion criteria for its use, but it should be noted that this score is less accurate in patients with certain conditions that can mimic the symptoms of PE, such as heart failure or pneumonia. It is also less reliable in pregnant women due to physiological changes that can affect the score parameters.
Reference
Jun-Hua Shen, Hong-Lin Chen, Jian-Rong Chen et al. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis. 2016 Apr;41(3):482-92.
Open reference URL